The Democrats’ Empty Threats of Oppression
New Hollywood Is Dead, Long Live Old Hollywood
Make America America Again
Election 2026: California Republicans Have a Chance
Should Race Realism Be Suppressed? The New York Times Thinks So
Stop Calling Them Democrats
Democrat Wins Show GOP Voters Aren't Motivated
Appeasement Has Failed: Britain Must Finally Proscribe the IRGC and Close Iran's Embassy
Negotiating Greenland from Denmark is Merely Deja Vu. The U.S. Took the Virgin...
Co-Creator of Dark Web Site 'Empire Market' Admits Role in $430M Illegal Marketplace
Soros Funded Nonprofit Doxxes Agents Involved in Alex Pretti Shooting
Detransitioner’s $2M Court Win Puts Medical Establishment on Notice
There's a Main Character Syndrome Pandemic on the Left
Illegal Alien Charged After Allegedly Firing Rifle on Dallas Bridge During New Year’s...
Massachusetts Auditor Uncovers $4.8 Million in Benefit Fraud in 2025's Fourth Quarter
Tipsheet

Doctors Blast FDA Rush to Approve Fourth COVID Vaccine Dose

(AP Photo/Rogelio V. Solis)

The Food and Drug Administration is expected to approve a fourth dose of Pfizer and Moderna's Wuhan coronavirus vaccine this week, despite a lack of clinical data showing they are effective or necessary.

Advertisement

"Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults," CBS News reported late last week. "The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors."

Doctors truly focused on following the science, not political science, are blasting the decision.  

"The FDA’s vaccine regulation is sliding further into the abyss. Last week, Pfizer announced that it would seek emergency-use authorization for a fourth dose of its mRNA vaccine, based on the original Wuhan strain of Covid-19, in people over 65. Meantime, Moderna announced that it was seeking an even larger market share: a fourth dose in anyone over 18, based on its original mRNA vaccine. If the FDA moves forward on authorizing either product, it will cement a dangerous precedent: inadequate evidence being used to justify widespread vaccination for years to come," Dr. Vinay Prasad writes for City Journal. "The data supporting fourth doses aren’t up to medicine’s gold standard: a randomized trial. Instead, we have two observational studies comparing people who rushed to be boosted with those who didn’t."

Advertisement

Related:

MANDATE

As noted, a number of longtime FDA officials resigned last fall due to the approval process being rushed and concerns about side effects -- specifically enlargement of the heart in young people -- being ignored. Not to mention the CDC is just now getting around to studying side effects for women who have experienced serious changes in their menstruation cycles. 

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement